MURINE MODELS OF HYPOTHYROIDISM AND CONGENITAL DEAFNESS
Project Number5R01DC004566-03
Contact PI/Project LeaderWALSH, EDWARD J
Awardee OrganizationFATHER FLANAGAN'S BOYS' HOME
Description
Abstract Text
DESCRIPTION (provided by applicant): The overall, long-term goal of the
research proposed in this application is to determine the anatomical and
physiological basis of peripheral auditory anomalies associated with congenital
hypothyroidism and to initiate an investigation into the molecular nature of
associated deficits. In doing so, we hope to expand our understanding of
thyroid hormone's role in the normal development of the inner ear and extend
our understanding of the auditory consequences of hypothyroidism by considering
the relative contribution that discrete inner ear tissues and structures make
in the pathogenesis of the disease. The Tshrhyt mutant mouse is ideally suited
to meet the needs of the proposed research and will serve as the primary model
of hypothyroidism in the proposed study. We also propose to study normal BALB/c
mice rendered hypothyroid through the actions of the anti-thyroid drugs,
propylthiouracil (PTU) and methimazole (MMI), in an effort to establish a model
of hypothyroidism-induced otopathology that will allow us to clarify
differences reported in the literature regarding the effects of thyroid hormone
deficiency on the auditory periphery, as well as the capacity of thyroid
hormone to restore function in diseased animals.
The chief hypothesis being tested in this proposal is that abnormal cochlear
amplification represents an enduring defect of hypothyroidism-induced
otopathology and that normal passive transduction is acquired developmentally
over a protracted time course. In that context, in addition to experiments
designed to address the primary question directly using in vivo recordings
(ABR, CM and DPOAE), as well as in vitro recordings from outer hair cells, we
plan to study the morphological and the functional properties of the tectorial
membrane, along with its chemical composition, to determine its role in the
pathogenesis of the disease. The role of other passive aspects of transduction
(e.g., endocochlear potential) will be assessed directly. We also plan to take
the first step in a study aimed at determining the molecular and genetic basis
of hypothyroidism, using RT-PCR and in situ hybridization to study the
expression of transcripts that may affect the expression of cochlear
amplification. Finally, we propose to explore the intriguing possibility that
the efferent OC system may influence the development of peripheral auditory
function. If the main hypotheses proposed here are affirmed, the existing model
of auditory system pathology induced by hypothyroidism will be fundamentally
revised.
National Institute on Deafness and Other Communication Disorders
CFDA Code
173
DUNS Number
073136806
UEI
H1TYS4PK8EC5
Project Start Date
24-September-2001
Project End Date
31-August-2006
Budget Start Date
01-September-2003
Budget End Date
31-August-2004
Project Funding Information for 2003
Total Funding
$327,600
Direct Costs
$227,500
Indirect Costs
$100,100
Year
Funding IC
FY Total Cost by IC
2003
National Institute on Deafness and Other Communication Disorders
$327,600
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DC004566-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DC004566-03
Patents
No Patents information available for 5R01DC004566-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DC004566-03
Clinical Studies
No Clinical Studies information available for 5R01DC004566-03
News and More
Related News Releases
No news release information available for 5R01DC004566-03
History
No Historical information available for 5R01DC004566-03
Similar Projects
No Similar Projects information available for 5R01DC004566-03